Trials / Completed
CompletedNCT01652365
Feasibility and Impact of Malaria Rapid Diagnostic Tests in the African Retail Sector
Evaluation of the Feasibility and Impact of Introducing Malaria Rapid Diagnostic Tests in the Retail Sector: A Randomized Controlled Trial in Eastern Uganda
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,800 (actual)
- Sponsor
- Harvard School of Public Health (HSPH) · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the feasibility and impact of introducing subsidized malaria rapid diagnostic tests (RDTs) into retail sector drug shops in Uganda. This is a randomized controlled trial at the village level, taking place in 6 districts in Eastern Uganda. Licensed drug shops in selected villages were trained in proper RDT storage, administration, interpretation and disposal and were given access to subsidized RDTs for sale. This study explores whether drug shop owners--when given access to training and subsidized RDTs--will choose to promote and sell RDTs to customers and, if so, at what volume and what price. The investigators also explore whether shops will safely store, administer, interpret and dispose of RDTs and to what extent they will use RDT results to guide treatment recommendations. Finally, the study explores whether making RDTs available for sale in local drug shops has a community level impact on diagnostic testing and appropriate treatment for malaria.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | RDT Training and Subsidy Offered | |
| BEHAVIORAL | Information/Education Campaign |
Timeline
- Start date
- 2011-03-01
- Primary completion
- 2012-06-01
- Completion
- 2012-06-01
- First posted
- 2012-07-30
- Last updated
- 2012-07-30
Locations
2 sites across 1 country: Uganda
Source: ClinicalTrials.gov record NCT01652365. Inclusion in this directory is not an endorsement.